Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Business Insider
23d
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
The NLRP3 inflammasome is a key inflammation driver linked to central nervous system (CNS) disorders, metabolic diseases, and aging-related conditions. JOTROL, Jupiter’s flagship product ...
Yahoo Finance
23d
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
Jupiter, Florida, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
To accept parcels from China
Places global staff on leave
FBI agents sue DOJ
Plans to take over Gaza
Ohio warehouse shooting
Hyde announces retirement
To cut 8.5% of its workforce
All 67 bodies recovered
Atmospheric river slams CA
Offers buyouts to workforce
Arrested on multiple charges
FireAid raises over $100M
To stencil 'Choose Love'
Key Bridge design unveiled
US private payrolls rise
Abuse scandal settlement
Judge tosses last charge
Former member sues Trump
World War II pilot dies
Google drops AI pledge
Baby elephant at OR Zoo
US trade deficit widens
Blocks citizenship order
When is the next full moon?
Lose trademark ownership
Eggs worth $40K stolen
Neil Jacobs to lead NOAA
Renowned saxophonist dies
Synagogue shooting plea
Feedback